Claus Hellerbrand
#159,833
Most Influential Person Now
Claus Hellerbrand's AcademicInfluence.com Rankings
Claus Hellerbrandbiology Degrees
Biology
#12560
World Rank
#16043
Historical Rank
Cell Biology
#672
World Rank
#686
Historical Rank
Molecular Biology
#2052
World Rank
#2084
Historical Rank
Biochemistry
#2150
World Rank
#2295
Historical Rank

Download Badge
Biology
Why Is Claus Hellerbrand Influential?
(Suggest an Edit or Addition)Claus Hellerbrand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013) (1068)
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. (1998) (456)
- A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis (2015) (376)
- The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. (1999) (339)
- Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. (2014) (325)
- Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes (2009) (317)
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis (2018) (316)
- PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis (2006) (304)
- Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis (2010) (301)
- Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians (2010) (291)
- GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. (2009) (288)
- Intestinal fungi contribute to development of alcoholic liver disease (2017) (273)
- Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans (2005) (262)
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma (2009) (258)
- Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. (1998) (255)
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. (2011) (224)
- Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells (1997) (215)
- PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. (2006) (211)
- Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis (2004) (207)
- A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. (2003) (206)
- Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma (2009) (206)
- Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells (2009) (204)
- Animal models of chronic liver diseases. (2013) (188)
- Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice (2013) (184)
- The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis (2008) (179)
- Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super‐repressor (1998) (171)
- Reduced expression of CYLD in human colon and hepatocellular carcinomas. (2007) (167)
- Association between serum ferritin and the insulin resistance syndrome in a representative population. (2006) (167)
- GLUT1 as a therapeutic target in hepatocellular carcinoma (2009) (167)
- Expression of fatty acid synthase in nonalcoholic fatty liver disease. (2010) (167)
- Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications (2010) (167)
- Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells (1996) (161)
- Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. (2016) (161)
- DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma (2011) (147)
- Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. (2009) (147)
- Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas (2009) (134)
- Hypoxia‐inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia‐inducible factor‐1 (2010) (133)
- Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. (2008) (127)
- Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer (2011) (126)
- Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors (1998) (125)
- Hepatic stellate cells—the pericytes in the liver (2013) (120)
- miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. (2013) (115)
- Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. (2010) (113)
- Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. (2011) (110)
- Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkers (2006) (109)
- Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis (2012) (102)
- Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC (2011) (101)
- TNFalpha is required for cholestasis-induced liver fibrosis in the mouse. (2009) (100)
- Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. (2010) (96)
- BMP-9 interferes with liver regeneration and promotes liver fibrosis (2017) (94)
- Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. (2010) (94)
- Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis (2018) (93)
- [S2k Guideline non-alcoholic fatty liver disease]. (2015) (92)
- Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. (1998) (92)
- Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. (2006) (91)
- Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen. (2015) (90)
- Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression (2009) (89)
- The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. (2005) (89)
- Regulatory Role of the Conserved Stem-Loop Structure at the 5′ End of Collagen α1(I) mRNA (1999) (89)
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013) (84)
- Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. (1998) (83)
- A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. (2009) (82)
- HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. (2003) (81)
- Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell‐cycle control and apoptosis (2014) (79)
- Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells (2015) (79)
- Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis (2017) (78)
- Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells. (2004) (78)
- Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. (2006) (77)
- Transforming growth factor-β1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection (2005) (77)
- Increased expression of c-Jun in nonalcoholic fatty liver disease (2013) (76)
- Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma (2004) (76)
- Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease. (2004) (74)
- Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. (2009) (73)
- Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition (2010) (73)
- A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. (2011) (72)
- Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice (2014) (72)
- Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. (2004) (71)
- The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. (2008) (68)
- Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. (2008) (68)
- Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance (2017) (68)
- The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma (2007) (67)
- ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo (2008) (67)
- Frequent expression of the novel cancer testis antigen MAGE‐C2/CT‐10 in hepatocellular carcinoma (2009) (65)
- Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different (2014) (64)
- Hepatitis C – contamination of toothbrushes: myth or reality? (2006) (63)
- Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells (2007) (61)
- Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. (2010) (61)
- Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. (2010) (60)
- Targeting heat‐shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice (2009) (60)
- Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver (2012) (60)
- Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro (2019) (58)
- CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. (2014) (58)
- miR‐30c and miR‐193 are a part of the TGF‐β‐dependent regulatory network controlling extracellular matrix genes in liver fibrosis (2015) (57)
- Expression of Serotonin Receptors in Human Hepatocellular Cancer (2012) (56)
- Comparison of interobserver agreement for different scoring systems for reflux esophagitis: Impact of level of experience. (2004) (55)
- Xanthohumol feeding does not impair organ function and homoeostasis in mice. (2010) (55)
- Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. (2010) (55)
- Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). (2011) (54)
- Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis (2011) (53)
- Deregulation of protein methylation in melanoma. (2013) (52)
- Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage (2014) (51)
- The potential of silymarin for the treatment of hepatic disorders (2016) (51)
- Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. (2010) (49)
- Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. (2010) (47)
- Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease (2016) (47)
- Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. (2006) (47)
- Repression of Cytochrome P450 Activity in Human Hepatocytes in Vitro by a Novel Hepatotrophic Factor, Augmenter of Liver Regeneration (2006) (47)
- Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. (2012) (46)
- The Marburg I variant (G534E) of the factor VII–activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet‐derived growth factor BB (2009) (46)
- FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice. (2010) (45)
- TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. (2005) (45)
- Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. (2005) (45)
- Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma (2007) (44)
- Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome. (2010) (42)
- The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels (2015) (41)
- Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease (2014) (41)
- Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. (2011) (41)
- Specific Expression and Regulation of the New Melanoma Inhibitory Activity-related Gene MIA2 in Hepatocytes* (2003) (40)
- Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. (2007) (40)
- Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. (2005) (40)
- Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value (2012) (39)
- Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function. (2011) (39)
- A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. (2008) (38)
- Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats (2015) (37)
- Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. (2015) (37)
- Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models (2017) (37)
- Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition (2018) (37)
- Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). (2015) (37)
- High predictive value ofToxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis (1996) (36)
- Hepatocellular Carcinoma in Southern Germany: Epidemiological and Clinicopathological Characteristics and Risk Factors (2002) (36)
- Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction (2011) (36)
- Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis. (2010) (35)
- Prevents Apoptosis and Liver Dysfunction during Liver Regeneration (1998) (35)
- Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection. (2003) (34)
- Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. (2014) (34)
- Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels (2016) (34)
- Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease (2003) (34)
- Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. (2013) (34)
- Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal (2009) (34)
- Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. (2005) (33)
- Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury. (2013) (33)
- ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis (2017) (32)
- Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes (2011) (32)
- Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice (2016) (32)
- Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. (2005) (32)
- Uncoupling of sympathetic nervous system and hypothalamic‐pituitary‐adrenal axis in cirrhosis (2008) (32)
- mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma (2015) (32)
- Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma1 (2019) (32)
- Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7 (2014) (31)
- MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. (2011) (31)
- Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy (2011) (31)
- Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. (1998) (30)
- Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. (2010) (30)
- Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany. (2010) (30)
- Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma (2019) (29)
- Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma (2005) (29)
- Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. (2011) (29)
- Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. (2008) (29)
- Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis. (2009) (29)
- Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course (2007) (28)
- Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. (2013) (27)
- Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet. (2013) (27)
- Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma (2011) (27)
- Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro. (2012) (26)
- Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. (2005) (26)
- Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition (2012) (25)
- Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option (2017) (25)
- LPS-mediated NFκB activation varies between activated human hepatic stellate cells from different donors (2004) (25)
- Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma (2015) (25)
- Obesity and Fatty Liver Are ‘Grease’ for the Machinery of Hepatic Fibrosis (2011) (25)
- Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration. (2011) (24)
- BMP6-induced modulation of the tumor micro-milieu (2018) (24)
- Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. (2011) (24)
- Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis (2009) (23)
- Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro (2015) (23)
- Xanthohumol uptake and intracellular kinetics in hepatocytes, hepatic stellate cells, and intestinal cells. (2011) (23)
- Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin (2005) (23)
- Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. (2011) (23)
- Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. (2018) (22)
- Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas. (2014) (21)
- Cylindromatosis—A Protective Molecule against Liver Diseases (2016) (21)
- Rapid genetic screening for hemochromatosis using automated SSCP-based capillary electrophoresis (SSCP-CE). (1999) (21)
- Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro. (2018) (21)
- In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers (2005) (21)
- Early changes in the liver‐soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet (2012) (21)
- Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10. (2005) (20)
- Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y. (2013) (20)
- FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. (2010) (19)
- Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (2019) (19)
- MicroRNA‐622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma (2018) (19)
- Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stellate cells: implications for leukocyte extravasation and liver metastasis. (2009) (19)
- Olive Oil Attenuates the Cholesterol-induced Development of Nonalcoholic Steatohepatitis Despite Increased Insulin Resistance in a Rodent Model (2013) (19)
- Role of fibroblast growth factor signalling in hepatic fibrosis (2021) (18)
- Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells in vitro. (2012) (17)
- Dietary glycine blunts liver injury after bile duct ligation in rats. (2008) (17)
- Characterization of glycolysis-related gene expression in malignant melanoma. (2019) (17)
- Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer (2020) (17)
- Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis12 (2018) (17)
- Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation (2018) (17)
- Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro. (2011) (16)
- Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model. (2015) (16)
- LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors. (2003) (15)
- Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis (2016) (15)
- Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis. (2007) (15)
- Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma (2011) (15)
- Effect of acute beer ingestion on the liver: studies in female mice (2015) (15)
- Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. (2013) (15)
- Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro (2019) (14)
- Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models. (2010) (14)
- Use of capillary electrophoresis for high throughput screening in biomedical applications. A minireview. (2000) (14)
- Role of melanoma inhibitory activity in melanocyte senescence (2019) (14)
- Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique. (2001) (14)
- Pathophysiological Similarities and Synergisms in Alcoholic and Non-Alcoholic Steatohepatitis (2011) (14)
- Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease. (2008) (14)
- Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension. (2010) (13)
- Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease. (2011) (13)
- Post-transcriptional regulation of collagen alpha 1(I) mRNA in hepatic stellate cells. (1995) (13)
- No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. (2008) (13)
- Alpha‐fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas (2009) (13)
- An iso-α-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice. (2018) (13)
- Expression and function of the atypical cadherin FAT1 in chronic liver disease. (2012) (13)
- Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells (2021) (12)
- Characterization of rat and human Kupffer cells after cryopreservation. (2007) (12)
- Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma (2020) (12)
- BMP-9 Modulates the Hepatic Responses to LPS (2020) (12)
- A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY CONFIRMS PNPLA 3 AND IDENTIFIES TM 6 SF 2 AND MBOAT 7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS (2017) (12)
- Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma (2020) (11)
- Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease. (2019) (11)
- Genomewide genetic association studies in hepatology: The end of searching for the needle in the haystack? (2007) (10)
- Herbs to treat liver diseases: More than placebo? (2015) (9)
- Chronic Psychosocial Stress in Mice Is Associated With Increased Acid Sphingomyelinase Activity in Liver and Serum and With Hepatic C16:0-Ceramide Accumulation (2018) (9)
- Analysis of carbohydrate deficient transferrin serum levels during abstinence. (2012) (9)
- Molecular targets for antifibrotic therapy in liver disease: using magic bullets for crossfire rather than a one-sided shotgun attack (2013) (9)
- Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye. (2021) (8)
- Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview (2020) (8)
- Effect of melanoma cells on proliferation and migration of activated hepatic stellate cells in vitro. (2017) (8)
- LightCycler-analysis of the Transforming Growth Factor-beta1 Codon 25 Gene Polymorphism in German Patients with Chronic Hepatitis C Infection (2004) (8)
- Iron-induced expression of BMP6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo (2010) (8)
- Expression and Function of Methylthioadenosine Phosphorylase in Chronic Liver Disease (2013) (7)
- The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression (2019) (7)
- Enhanced expression of BMP 6 inhibits hepatic fi brosis in non-alcoholic fatty liver disease (2015) (6)
- Inhibition of proinllammatory molecule expression by adenovirus-mediated expression of an NFkB super repressor in activated hepatic stellate cells (1998) (6)
- Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun’s Nuclear Translocation and Activity (2019) (5)
- Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11 (2021) (5)
- Inhibition of NF (cid:107) B in Activated Rat Hepatic Stellate Cells by Proteasome Inhibitors and an I (cid:107) B Super-Repressor (1998) (5)
- Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases. (2009) (5)
- Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro (2019) (5)
- Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. (2004) (5)
- Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. (2015) (4)
- β-Arrestin2 is increased in liver fibrosis in humans and rodents (2020) (4)
- Identification of cytochrome CYP2E1 as critical mediator of alcohol effects on steatotic hepatocytes (2015) (4)
- Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury (2020) (4)
- 320 Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease (2004) (4)
- Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism. (2018) (3)
- Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma. (2005) (3)
- with progression of liver fibrosis in Caucasians with chronic hepatitis C infection (2005) (3)
- Characterization of the human zinc finger protein 267 promoter: essential role of nuclear factor Y. (2005) (3)
- Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma (2005) (3)
- 316 FAT1 EXPRESSION IS INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTES TUMORIGENESIS (2012) (3)
- OP0284 Long Noncoding RNA MIR503HG is a Novel Factor in the Pathogenesis of Systemic Sclerosis (2015) (3)
- Promotor-Hypermethylation Is Causing Functional Relevant Downregulation of Methylthioadenosine Phosphorylase (MTAP) Expression in Hepatocellular Carcinoma (2005) (3)
- Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire (2018) (3)
- Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs (2022) (3)
- Re-evaluation of the genetic cirrhosis risk score in patients with chronic hepatitis C virus infection (2009) (3)
- Interstrain differences in susceptibility to non-alcoholic steatohepatitis (2011) (3)
- Down-regulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma (2011) (2)
- Enhanced TLR4 expression in steatotic hepatocytes (2012) (2)
- Expression of different histone deacetylases and functional effects of histone deacetylase inhibitors in hepatocellular carcinoma (2018) (2)
- 151 Protective Effect of Pd-L1/Pd-1 in Acute Hepatic Ischemia-Reperfusion Injury (2008) (2)
- HFE gene mutations in patients with hepatocellular carcinoma (2000) (2)
- Increased expression of pregnancy-associated plasma protein-A (PAPP-A) in hepatic stellate cells correlates with hepatic fibrosis and can be detected in the serum of patients with liver disease (2016) (2)
- Effect of increased glucose transporter 1 (GLUT1) expression in activated hepatic stellate cells (2013) (2)
- Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanisms. (2022) (2)
- Expression profile of fibroblast growth factors in hepatic stellate cells and experimental models of liver fibrosis (2018) (2)
- Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases (2022) (2)
- Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma (2021) (2)
- Tumorsuppressive MicroRNA-188-5p Reveals Novel Oncogenes for Hepatocellular Carcinoma (2016) (2)
- Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche (2022) (1)
- Uptake of xanthohumol in human liver and intestinal cells (2009) (1)
- UVB radiation represses CYLD expression in melanocytes (2017) (1)
- Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of hepatocellular carcinoma (2010) (1)
- Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1 (2021) (1)
- PD1/PD-L1 protects from inflammation and fibrosis in non-alcoholic steatohepatitis (2009) (1)
- Posters02a. Cirrhosis and its Complications: Pathophysiology601 miR-133a MEDIATES TGF-b-DEPENDENT DE-REPRESSION OF COLLAGEN-SYNTHESIS IN HEPATIC STELLATE CELLS DURING LIVER FIBROSIS (2013) (1)
- 139 Complement factor 5 (C5) is a genetic determinant of liver fibrogenesis in mice and humans (2003) (1)
- Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer (2021) (1)
- Elevated serum IGE is a specific marker for alcohol-related liver cirrhosis (2000) (1)
- PD1 expression inhibits hepoatic inflammation and fibrosis in non-alcoholic steatohepatitis (2011) (1)
- Combination of psychosocial stress and a NASH-inducing diet in mice (2013) (1)
- Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells (2011) (1)
- Increased expression of histone deacetylase 7 during hepatic stellate cell activation promotes pro-fibrogenic gene expression (2015) (1)
- Corrigendum to “Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver” [Molecular and Cellular Endocrinology 349 (2012) 248–254] (2012) (1)
- Hop bitter acids exhibit anti-fibrogenic effects an hepatic stellate cells in vitro (2011) (1)
- [104] FUNCTIONAL AND GENETIC INTERACTION OF THE CHEMOKINES CCL (RANTES) AND CXCL (PF) IN CHRONIC LIVER DISEASES IN MICE AND HUMANS (2007) (1)
- A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women (2022) (1)
- [772] LIPID ACCUMULATION IN HEPATOCYTES INDUCES ACTIVATION AND PRO-FIBROTIC GENE EXPRESSION IN HEPATIC STELLATE CELLS - A NEW IN VITRO MODEL TO STUDY FIBROGENESIS IN NASH (2007) (1)
- Analysis of Molecular Mechanisms of 5-Fluorouracil Induced Steatosis and Inflammation in Vitro and in Mice (2016) (1)
- The potent modulator of cholesterol biosynthesis insulin-induced gene 1 (INSIG1) is a novel hypoxia-regulated tumor suppressor in hepatocellular carcinoma (2019) (1)
- A novel in vitro model of alcohol-induced hepatic fibrogenesis (2011) (1)
- MMP–9 activity is increased by adiponectin in primary human hepatocytes but negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis (2012) (1)
- Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decrease during alcohol withdrawal (2008) (1)
- Circulating Serum Markers Correlate with Liver Fibrosis in Patients with Chronic Hepatitis C (2005) (1)
- Glucose transporter isoform 1 (GLUT1) expression enhances formation and growth of hepatic metastases (2013) (1)
- Identification of the chemokine CXCL9 (MIG) as a genetic modifier of liver fibrosis in patients with hepatitis C (2006) (1)
- GLUT1 and GLUT3 expression are increased in hepatocellular carcinoma and promote tumorigenesis (2009) (1)
- A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY IDENTIFIES TM6SF2 AND MBOAT7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS (2015) (1)
- GENETIC PREDISPOSITION FOR ALCOHOL-ASSOCIATED GASTROIN-TESTINAL CANCER IN HEAVY DRINKERS WITH THE ALCOHOL DEHYDROGENASE 1C*1 ALLELE. (2004) (1)
- 163 XANTHOHUMOL SUPPRESSES HEPATIC INFLAMMATORY RESPONSE TO ACUTE LIVER INJURY (2012) (1)
- A new model of synergistic effects of alcohol and high-fat diet on hepatic injury (2010) (1)
- Analysis of molecular mechanisms of 5-fluorouracil-induced hepatic steatosis and inflammation in vitro and in mice (2016) (1)
- Abstract 4373: Targeting FGFR system in a model of HCC (2012) (1)
- Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumor progression (2009) (1)
- Hop bitter acids inhibit PD-L1 expression and tumorigenicity of hepatocellular carcinoma cells (2012) (1)
- Elevated systemic monocyte chemoattractrant protein-1 levels in hepatic steatosis without significant hepatic inflammation (2011) (1)
- 6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma (2009) (1)
- Heterozygous p53 knockout affects development of obesity, insulin resistance and non-alcoholic steatohepatitis in mice fed with a Western type diet (2013) (1)
- Influence of DSS induced colitis in a model of experimental NASH (2009) (0)
- Hepatic steatosis enhances growth and invasiveness of hepatocellular carcinoma (2014) (0)
- Chronic and excessive alcohol consumption is causing elevated adiponectin serum levels (2006) (0)
- ALR expression indicates liver regeneration upon distinct tissue damage (2010) (0)
- The role of PI3K p110gamma in chronic liver injury (2012) (0)
- ERK and p38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
- 1252 Homozygosity for the alcoholdehydrogenase 3*1 allele is associated with hepatocellular carcinoma in alcohol-induced cirrhosis (2003) (0)
- Increased expression of the Glucose-transporter GLUT1 during hepatic stellate cell activation promotes hepatic fibrosis (2015) (0)
- Bone morphogenetic protein 13 is expressed by activated hepatic stellate cells and promotes tumorigenicity of hepatocellular carcinoma (2022) (0)
- The role of the pancreatic polypeptide-neuropeptide Y receptor 4-axis in hepatocellular carcinoma progression (2023) (0)
- Ferritin-Mediated Iron Seq uestration Stabilizes Hypoxia-Inducible Factor-1 a upon LPS Activation in the Presence of Ample Oxygen Graphical (2015) (0)
- 706 INFLUENCE OF DSS INDUCED COLITIS IN A MODEL OF EXPERIMENTAL NASH (2009) (0)
- Xanthohumol inhibits hepatitis B virus replication in vitro (2012) (0)
- Representation of human non-alcoholic fatty liver disease in murine models (2015) (0)
- Crucial role of beta-arrestin-2 in linking fibrogenesis and cancer (2020) (0)
- SY24-3PATHOPHYSIOLOGICAL SIMILARITIES AND SYNERGISMS IN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE (2015) (0)
- Expression of growth differentiation factor 5 in liver disease and cancer (2022) (0)
- 135 PD1/PD-L1 PROTECT FROM INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS (2009) (0)
- M1567 CpG Motifs Induce Proinflammatory Events in Hepatic Stellate Cells and Are Involved in Bile Duct Ligation-Induced Hepatic Fibrosis In Vivo (2008) (0)
- Expression of paracrine fibroblast growth factors in hepatic stellate cells and hepatic fibrosis (2021) (0)
- Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer (2021) (0)
- GLUT 1 expression favors formation and growth of hepatic metastasis (2012) (0)
- 999 HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLS (2010) (0)
- Expression and function of histone deacetylase 7 in hepatocellular carcinoma (2021) (0)
- 904 INCREASED EXPRESSION OF FAT1 IN HEPATOCELLULAR CARCINOMA PROMOTES TUMORIGENICITY (2010) (0)
- 1231 INTERSTRAIN DIFFERENCES IN SUSCEPTIBILITY TO NON-ALCOHOLIC STEATOHEPATITIS (2012) (0)
- S01-4Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease (2017) (0)
- Systemic spreading of intraperitoneal Staphylococcus aureus is increased in experimental liver cirrhosis but unaltered by splanchnic sympathectomy (2010) (0)
- Hepatic steatosis potentiates irinotecan-induced hepatocellular injury (2018) (0)
- Histone deacetylases (HDAC) expressions in HCC and functional effects of HDAC inhibitors in liver cancer cells (2020) (0)
- CYLD-Mediated Upregulation of Hepatocyte Growth Factor Prevents Hepatic Injury and Fibrosis (2013) (0)
- 504 GLUT1 AND GLUT3 EXPRESSION ARE INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTE TUMORIGENICITY (2009) (0)
- Copy number variation of the CCL3L1 gene in chronic HCV infection: Influence on susceptibility and fibro-inflammatory response (2007) (0)
- Cytochrome Cyp2e1 is critical for joint effects of alcohol and lipids on hepatocellular steatosis and inflammation (2013) (0)
- P0298 : Glucose transporter isoform 1 (GLUT1) expression determines hepatic metastasis of melanoma cells (2015) (0)
- IDENTIFICATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2111B (FGFRZIIIB) AS TUMOR SUPPRESSOR IN H EPATOCANCE ROGEN ESlS (2005) (0)
- Anti-fibrogenic effects of sylimarin vary significantly in human hepatic stellate cells from different donors (2014) (0)
- Role of Fibroblast Growth Factor 9 in bile acid homeostasis (2022) (0)
- The MIA-2 protein (2003) (0)
- Lipid-loaded hepatocytes release soluble factors that activate hepatic stellate cells: a new in vitro model to study fibrogenesis in NASH (2008) (0)
- Adiponectin downregulates connective tissue growth factor in hepatocytes and hepatic stellate cells (2010) (0)
- The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)
- Subject Index Vol. 28, 2010 (2011) (0)
- Increased expression of the glucose transporter GLUT1 in liver fibrosis (2012) (0)
- Mass spectrometry based metabolomics to study the development of Non-alcoholic steatohepatitis (2011) (0)
- Variation of the expression of different Histone deacetylases (HDACs) and the functional effects of HDAC-inhibitors in hepatocellular carcinoma (2019) (0)
- Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates inflammation and fibrosis in experimental non alcoholic steatohepatitis but protects against bile duct ligation induced liver fibrosis in vivo (2010) (0)
- BMP6 protects against hepatic inflammation and fibrosis in experimental NASH models (2012) (0)
- 1249 IN VITRO AND IN VIVO MODELS FOR CHEMOTHERAPY-ASSOCIATED STEATOHEPATITIS REVEAL AN EFFECT OF IRINOTECAN ON FATTY ACID BINDING PROTEIN EXPRESSION (2012) (0)
- Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis (2022) (0)
- Contents Vol. 28, 2010 (2011) (0)
- Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis (2016) (0)
- P1125 : Alcohol induces pathological as well as protective mechanisms in steatotic hepatocytes (2015) (0)
- [69] IDENTIFICATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2IIIB (FGFR2IIIB) AS TUMOR SUPPRESSOR IN HEPATOCANCEROGENESIS (2007) (0)
- [453] ASSOCIATION OF CCBP2, A SCAVENGER RECEPTOR FOR INFLAMMATORY CC CHEMOKINES, WITH LIVER INFLAMMATION IN MICE AND HUMANS (2007) (0)
- THU-465-Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma (2019) (0)
- Expression and function of methylthioadenosine phosphorylase (MTAP) in activated hepatic stellate (2014) (0)
- Association between serum ferritin and the insulin resistance syndrome (IRS) in a representative German population (2004) (0)
- Autophagy impairment and ERK and p38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
- Sorafenib-resistance is mediated by a novel Kirsten rat sarcoma-microRNA-axis in hepatocellular carcinoma (2018) (0)
- Different Effects of the Functional MCP–1 Polymorphism (A–2518G) on Hepatic Fibrosis and Hepatocancerogenesis (2005) (0)
- Xanthohumol suppresses hepatic inflammatory response to warm ischemia-reperfusion injury (2012) (0)
- The long non-coding RNAs lnc-ADM-2 and lnc-NBPF3-9 represent potential novel targets in hepatocellular carcinoma (2023) (0)
- 559 ANALYSIS OF A PROMOTER POLYMORPHISM OF THE GLUT1 GENE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2010) (0)
- Glucose transporter isoform 1 (GLUT1) expression determines tumorigenicity of melanoma cells and their potential to form hepatic metastasis (2014) (0)
- Genet ics Correlation between Iron Status and Genetic Hemochromatosis ( Codon C 282 Y ) in a Large German Population (2003) (0)
- Systemic chemical sympathectomy does not alter the long-term course of disease in a murine model of non-alcoholic steatohepatitis (2011) (0)
- The hop chalcone xanthohumol beneficially affects hepatocellular lipid metabolism (2011) (0)
- 928 Deficiency of Intestinal Mucin-2 Protects From Alcoholic Liver Disease in Mice (2012) (0)
- Activated human hepatic stellate cells express CD14 and toll like receptors 2 and 4 (TLR-2, TLR-4) (2000) (0)
- Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis (2020) (0)
- P-13ISO-ALPHA-ACIDS FROM HOPS ATTENUATE ACUTE ALCOHOL-INDUCED LIVER STEATOSIS IN MICE (2015) (0)
- Gender specific differences in Western-type diet induced steatohepatitis in mice (2018) (0)
- Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity (2011) (0)
- Expression of growth differentiation factor 5 in liver fibrosis and cancer (2023) (0)
- Subject Index Vol. 19, 2001 (2002) (0)
- Role of methylthioadenosine phosphorylase (MTAP) in hepatic stellate cell activation (2013) (0)
- Xanthohumol improves glucose tolerance and inhibits hepatic steatosis, inflammation and fibrogenesis in a murine model of non-alcoholic steatohepatitis (2012) (0)
- Activated hepatic stellate cells promote growth and inhibit apoptosis of hepatocellular carcinoma (2006) (0)
- Irinotecan induced disturbance of bile acid homeostasis promotes hepatocellular injury and inflammation (2018) (0)
- Four-and-a-half LIM-domain protein affects diet induced (hepatic) steatosis and lipid droplet formation (2018) (0)
- A steatotic environment promotes the progression of hepatocellular carcinoma via direct and indirect mechanisms (2015) (0)
- Causal modeling of stroma-cancer cell communication (2015) (0)
- Alcohol dehydrogenase 3∗1 genotype is associated with hepatocellular carcinoma in alcohol-induced liver cirrhosis (2003) (0)
- Enhanced Expression of Fibroblast Growth Factor 9 in Hepatic Fibrosis (2022) (0)
- Processing of MIA2 is important for its tumor suppressor function in hepatocellular carcinoma (2015) (0)
- 364 DOWNREGULATION OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) EXPRESSION IN CHRONIC LIVER DISEASE PROMOTES HEPATIC INFLAMMATION AND FIBROSIS (2012) (0)
- NFκB mediates LPS-induced expression of IL-6 and ICAM-1 in activated hepatic stellate cells, a process blocked by proteasome inhibitors (1998) (0)
- Pregnancy-associated plasma protein-A is increased in hepatic fibrosis and affects proliferation and activation of hepatic stellate cells (2018) (0)
- A novel microRNA-MAPK14-ATF2 axis contributes to hepatocellular carcinoma progression and sorafenib-resistance (2023) (0)
- Expression and function of neuroblastoma RAS viral oncogene homolog (NRAS) in hepatocellular carcinoma (2019) (0)
- A novel in vitro model for joint effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation (2013) (0)
- Four-and-a-half LIM-domain protein (FHL2) affects diet induced obesity, diabetes and hepatic steatosis and inflammation (2022) (0)
- Adenoviral gene delivery of interleukin-10 inhibits kupffer cells avtivation in vitro (2007) (0)
- CYP2E1 is a central mediator for the synergistic effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation (2014) (0)
- Impaired intestinal defensin production leads to bacterial translocation and subsequently aggravates hepatic inflammation and fibrogenesis in an experimental NASH model – a new second hit (2010) (0)
- Rapamycin aggravates experimental non alcoholic steatohepatitis in mice (2011) (0)
- 79 The role of genetic polymorphisms of matrixmetallo-proteinase-3 and transforming growth factor beta-1 in alcoholic liver cirrhosis (2004) (0)
- Atrophin 2 expression in chronic liver disease functionally affects activated hepatic stellate cells (2012) (0)
- Expression and function of glucose transporter 1 (GLUT1) expression in activated hepatic stellate cells (2014) (0)
- 313 Expression pattern of the novel melanoma inhibitory activity gene 2 (MIA2) in healthy and diseased human liver (2004) (0)
- Downregulation of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease promotes hepatic inflammation and fibrosis (2012) (0)
- Serum markers for hepatic fibrosis in chronic hepatitis C (2000) (0)
- [Liver histology in hepatitis C: correlation with different biochemical and virological parameters]. (2000) (0)
- 928 DEFICIENCY OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AGGRAVATES INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON ALCOHOLIC STEATOHEPATITIS BUT PROTECTS AGAINST BILE DUCT LIGATION INDUCED FIBROSIS IN VIVO (2010) (0)
- 700 LIVER REGENERATION AUGMENTING PROTEIN ALR REDUCES LIPOTOXICITY AND PROFIBROGENIC GENE EXPRESSION IN VITRO (2009) (0)
- Contents Vol. 19, 2001 (2002) (0)
- Expression and Function of Fibroblast Growth Factor 9 in hepatocellular carcinoma (2020) (0)
- Secretion and Glycolysis of Human Monocytes Lactic Acid and Acidification Inhibit TNF (2011) (0)
- Hepatic steatosis potentiates irinotecan-induced hepatocellular injury via dysregulation of irinotecan-metabolizing enzymes (2018) (0)
- 983 LIPID ACCUMULATION INDUCES PRODUCTION OF PRO-INFLAMMATORY INTERLEUKIN-8 IN HUMAN HEPATOCYTES VIA ACTIVATION OF JNK - A POTENTIAL STEP IN THE PROGRESSION TO NASH (2008) (0)
- Aldosterone stimulates the non-genomic signaling pathway of the mineralocorticoid receptor in hepatic stellate cells (2015) (0)
- Increased expression of Fat1 in hepatocellular carcinoma promotes tumorigenicity (2010) (0)
- Liver and Immunology: Falk Workshop, Regensburg, January 2011 (2011) (0)
- P1115 : ERK And P38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
- Author's response to reviews Title: ENMD-1198, a novel tubulin-binding agent reduces HIF-1 and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo Authors: (2008) (0)
- Keratinocyte growth factor inhibits hepatic inflammation and fibrosis in murine models of hepatic injury (2014) (0)
- Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates inflammation and fibrosis in experimental NASH in vivo (2010) (0)
- Functional effects of monocarboxylate transporter 1 expression in activated hepatic stellate cells (2015) (0)
- Effects of Heme Oxygenase–1 Overexpression on Liver Injury after Bile Duct Ligation in Rats (2005) (0)
- Glucose transporter isoform 1 (GLUT1) expression in melanoma enhances formation and growth of hepatic metastases (2013) (0)
- 723 Expression of HDAC1, 2, 3 and 7 as a prognostic markers in hepatocellular carcinoma (2010) (0)
- Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation (2018) (0)
- Increased expression of pregnancy-associated plasma protein-A in activated hepatic stellate cells is a potential therapeutic target and serum marker of hepatic fibrosis (2018) (0)
- Expression and function of methylthioadenosine phosphorylase (MTAP) in chronic liver disease (2011) (0)
- Protective effects of Iso-Alpha Acids (IAA) on hepatic steatosis, inflammation and fibrosis (2014) (0)
- Repopulation of gene altered Kupffer cells to rat liver Studies in an ischemia-reperfusion model (2002) (0)
- Pregnancy-associated plasma protein-A as potential novel target and serum marker for hepatic fibrosis (2019) (0)
- Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma (2020) (0)
- Does it matter not only how much but also when we eat to induce fatty liver? (2011) (0)
- 510 THE FORKHEAD BOX A2 TRANSCRIPTION FACTOR REGULATES THE HEPATOTROPHIC PROTEIN ALR (AUGMENTER OF LIVER REGENERATION) (2008) (0)
- Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication (2023) (0)
- Loss of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity (2013) (0)
- 567 A functional polymorphism in the glutathione-S-transferase P1 gene determines the progression to cirrhosis in patients with hereditary hemochromatosis (2004) (0)
- Enhanced expression of bone morphogenetic protein endothelial cell-precursor derived regulator in liver fibrosis (2022) (0)
- Expression and function of Epithelial Splicing Regulatory Protein 1 in hepatocellular carcinoma (2020) (0)
- ' s response to reviews Title : ENMD-1198 , a novel tubulin-binding agent reduces HIF-1 and STAT 3 activity in human hepatocellular carcinoma ( HCC ) cells , and inhibits growth and vascularization in vivo (2008) (0)
- Association of polymorphous light eruption with NOD‐2 and TLR‐5 gene polymorphisms (2022) (0)
- Expression of Intercellular Adhesion Molecule 1 by Activated Hepatic Stellate Cells (1998) (0)
- Xanthohumol, a prenylated chalcone derived from hops (Humulus lupulus), inhibits hepatic metastasis (2016) (0)
- REGENSBURG HEPATIC STEATOSIS CAUSES INDUCTION OF THE CHEMOKINE RANTES IN THE ABSENCE OF SIGNIFICANT HEPATIC INFLAMMATION Inaugural – (2012) (0)
- KLINIK UND POLIKLINIK FÜR INNERE MEDIZIN I PROF. DR. MARTINA MÜLLER-SCHILLING DER MEDIZINISCHEN FAKULTÄT DER UNIVERSITÄT REGENSBURG ANALYSIS OF SYSTEMIC MONOCYTE CHEMOATTRACTANT PROTEIN-1 LEVELS IN PATIENTS WITH AND WITHOUT SONOGRAPHIC EVIDENT HEPATIC STEATOSIS Inaugural – Dissertation zur Erlan (2013) (0)
- Chapter 5 – Capillary Electrophoresis (2010) (0)
- Age and gender dependent differences in BMP6 mediated hepcidin expression and iron homeostasis (2011) (0)
- 109 The chemokine CXCL9 (MIG) is associated with liver fibrogenesis in mice and humans (2006) (0)
- Expression of fibroblast growth factor receptors in hepatocellular carcinoma (2022) (0)
- Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates hepatic inflammation and fibrosis in experimental NASH but protects against bile duct ligation induced liver fibrosis (2011) (0)
- 1232 XANTHOHUMOL IMPROVES GLUCOSE TOLERANCE AND INHIBITS HEPATIC STEATOSIS, INFLAMMATION AND FIBROGENESIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (2012) (0)
- Adiponectin elevates activin A and reduces follistatin via the adiponectin receptor 2 in primary human hepatocytes (2009) (0)
- Fibroblast growth factor 7 inhibits hepatic steatosis, inflammation and fibrosis in murine models of on non-alcoholic steatohepatitis (2015) (0)
- Down-regulation of Alk2 and hemojuvelin protects from disturbance of iron homeostasis by increased BMP expression in hepatocellular carcinoma (2010) (0)
- [Clinical and genetic aspects of hereditary hemochromatosis]. (2001) (0)
- Four-and-a-half LIM-domain protein (FHL2) affects diet induced (hepatic) steatosis and and lipid droplet formation (2018) (0)
- Synergistic effects of alcohol and high-fat diet on hepatic injury – a new model to study alcoholic steatohepatitis (2010) (0)
- 342 Methylthioadenosin phosphorylase (MTAP) expression is frequently lost in hepatocellular carcinoma (2004) (0)
- Functional effects of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease (2013) (0)
- Expression and function of the atypical cadherin Fat1 in liver fibrosis (2011) (0)
- Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatocellular Carcinoma (2020) (0)
- The hop constituent xanthohumol exhibits hepatoprotective effects against acute alcohol-induced liver injury (2018) (0)
- The common functional C(−159)T polymorphism of the LPS receptor CD14 does not influence the disease outcome in patients with chronic hepatitis C infection (2002) (0)
- Novel feedback inhibition of the let-7 microRNA regulator and stem cell marker Lin 28 homolog A by tumorsuppressor miR-622 in hepatocellular carcinoma (2018) (0)
- Subject Index Vol. 34, Suppl. 1, 2016 (2016) (0)
- Bile salts induce interleukin 8 expression in human intestinal epithelial cells (2001) (0)
- A novel Krueppel-like factor 12/Interleukin-6 signal transducer – microRNA-188-5 p interaction reveals therapeutic targets for hepatocellular carcinoma (2018) (0)
- IL–6 and IL–1 enhance hepatic expression of ALR (Augmenter of Liver Regeneration) (2008) (0)
- Gender differences in Western-type diet-induced alterations of lipid metabolisms in the liver and adipose tissue of mice (2021) (0)
- Doxorubicin induces tumorigenicity and chemotherapy resistance of residual hepatocellular carcinoma cells in vitro (2014) (0)
- A hepatocyte nuclear factor-3 site in ALR promoter is important for interleukin 6-induced expression (2009) (0)
- Meeting Report: Intestinal BMP6, a Master Gene for the Regulation of Iron Homeostasis (2011) (0)
- THE 5A/5A GENETIC POLYMORPHISMS OF MATRIXMETALLO-PROTEINASE-3 IS ASSOCIATED WITH THE PROGRESSION TO CIRRHOSIS IN ALCOHOLIC LIVER DISEASE. (2004) (0)
- Aging promotes hepatocellular steatosis, inflammation and fibrosis in non-alcoholic steatohepatitis in mice (2012) (0)
- Original Article Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver disease (2011) (0)
- Alcohol and a high-fat diet synergistically induce hepatic inflammation and fibrosis via TLR4 (2011) (0)
- S06-3EFFECTS OF THE HOP FLAVONOID XANTHOHUMOL ON ALCOHOL INDUCED LIVER INJURY (2017) (0)
- Lack of expression of methylthioadenosin phosphorylase (MTAP) in normal human colonic epithelial cells (2004) (0)
- Expression of the atypical cadherin Fat1 in hepatic fibrosis (2012) (0)
- The role of mechanistic target of rapamycin complex 2-component RICTOR in hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
- BMP6 protects against hepatic fibrosis in experimental NASH models (2011) (0)
- Role of Fibroblast Growth Factors and Their Receptors in Liver Fibrosis and Repair (2015) (0)
- Contribution of common variants in the complement factor H gene to fibrogenesis in chronic hepatitis C virus (HCV) infection (2007) (0)
- TNF receptor superfamily member 10 d is a novel diagnostic and therapeutic target in hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
- Role of enhanced bone morphogenetic protein-endothelial cell-precursor derived regulator in hepatocellular carcinoma (2022) (0)
- Aging promotes susceptibility to non-alcoholic steatohepatitis in mice (2011) (0)
- Identification of Fibroblast Growth Factor Receptor 2IIIb (FGFR2IIIb) as tumor suppressor in hepatocellular carcinoma (2008) (0)
- Human Intestinal Epithelial Cells B Super-Repressor in k of a Nuclear Factor Production by Adenovirus-Mediated Expression Inhibition of Proinflammatory Molecule (1997) (0)
- The fraktalkine receptor CX3CR1 is associated with progression of liver fibrosis in patients with chronic hepatitis C (2006) (0)
- Aging promotes progression of non-alcoholic fatty liver disease in mice (2013) (0)
- Augmenter of Liver Regeneration Modulates Hepatic Metabolism by Reduction of Cytochrom P450 Activity in Human Hepatocytes in Vitro (2005) (0)
- [130] ADENOVIRAL GENE DELIVERY OF INTERLEUKIN-10 REDUCES HEPATIC ISCHEMIA-REPERFUSION INJURY IN RATS THRU INHIBITION OF KUPFFER CELL ACTIVATION (2007) (0)
- Deficiency of PI3K enhances inflammation and fibrosis in experimental non alcoholic steatohepatitis but attenuates bile duct ligation induced fibrosis in vivo (2010) (0)
- Neprilysin-neuropeptide Y axis as target for treatment of liver fibrosis and portal hypertension (2020) (0)
- Antifibrotic properties of transarterial VSV oncolytic therapy for hepatocellular carcinoma in rats with TAA-induced liver fibrosis (2011) (0)
- In vitro and in vivo models for chemotherapy-associated steatohepatitis reveal an effect of irinotecan on fatty acid binding protein expression (2012) (0)
- 582 EXPRESSION OF HDAC ISOENZYMES AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA (2010) (0)
- Original Article Expression of fatty acid synthase in nonalcoholic fatty liver disease (2010) (0)
- The kinase inhibitor DMAT reduces experimental HCC growth in mice (2011) (0)
- Attenuation of lipotoxicity by liver regeneration protein ALR (2010) (0)
- Adenoviral gene delivery of interleukin-10 reduces hepatic ischemia-reperfusion injury in rats (2007) (0)
- Rare diseases of the digestive system (2016) (0)
- Corrigendum to “Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in-vitro” [Exp. Mol. Pathol. 91-3 (2011) 733–739] (2012) (0)
- Gender-specific differences in a murine model of non-alcoholic steatohepatitis (2013) (0)
- 403 EXPRESSION AND FUNCTION OF THE ATYPICAL CADHERIN FAT1 IN HEPATIC FIBROSIS (2012) (0)
- Role of fibroblast growth factor 9 in the regulation of hepatic bile acid homeostasis (2023) (0)
- Hepatic steatosis potentiates irinotecan-induced hepatocellular steatohepatitis via dysregulation of irinotecan-metabolizing enzymes (2019) (0)
- Regulation and function of Fibroblast Growth Factor Receptor 2IIIb (FGFR2IIIb) in hepatocancerogenesis (2007) (0)
- Analysis of a functional promoter polymorphism of the MCP–1 gene in patients with spontaneous bacterial peritonitis (2008) (0)
- Rapamycin decreases proinflammatory and profibrogenic gene expression in experimental NASH (2009) (0)
- Hepatic steatosis promotes growth and invasiveness of hepatocellular carcinoma cells in vitro and in vivo (2015) (0)
- Combined effects of polo-like kinase 1 and harvey rat sarcoma in hepatocellular carcinoma reveal novel therapeutic strategies (2018) (0)
- The long non-coding RNAs lncRNA-ADM-2 and lncRNA-NBPF3-9 outline potential novel targets for hepatocellular carcinoma (2018) (0)
- 1260 AGING PROMOTES HEPATOCELLULAR STEATOSIS, INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS IN MICE (2012) (0)
- Regulation and Function of the atypical cadherin FAT1 in hepatocellular carcinoma (2013) (0)
- P0278 : Hepatic steatosis and high circulating free fatty acid levels promote growth and invasiveness of hepatocellular carcinoma (2015) (0)
- Novel in vitro models of alcohol-mediated hepatic injury (2012) (0)
- Analysis of the expression and function of KIAA1199 in hepatocellular carcinoma (2020) (0)
- Chain length and saturation status of fatty acids significantly affect cellular injury and lipid metabolism of primary human hepatocytes (2019) (0)
- Hepatic stellate cells—the pericytes in the liver (2013) (0)
- HGF mediated downregulation of the novel gene MIA2 promotes progression of hepatocellular carcinoma (2007) (0)
- Cytokines induce NF- (cid:107) B in activated but not in quiescent rat hepatic stellate cells (1998) (0)
- Muscle RAS oncogene homolog is a novel therapeutic target gene contributing to hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
- Establishment of an in vitro model in which HBV promotes hepatocellular steatosis and lipotoxicity (2012) (0)
- Xanthohumol inhibits the development of non-alcoholic steatohepatitis by systemic as well as direct effects on hepatocellular lipid uptake (2013) (0)
- 928 ELEVATED ADIPONECTIN SERUM LEVELS IN PATIENTS WITH CHRONIC ALCOHOL ABUSE RAPIDLY DECREASE DURING ALCOHOL WITHDRAWAL (2008) (0)
- In vitro and in vivo models for irinotecan induced steatohepatitis (2013) (0)
- 98 The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Claus Hellerbrand?
Claus Hellerbrand is affiliated with the following schools: